🇺🇸 FDA
Pipeline program

vilamakitug

PT064

Phase 2 small_molecule active

Quick answer

vilamakitug for Axial Spondyloarthritis is a Phase 2 program (small_molecule) at XBiotech with 1 ClinicalTrials.gov record(s).

Program details

Company
XBiotech
Indication
Axial Spondyloarthritis
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials